Julia A. Beaver, M.D.
Director, Division of Oncology Products 1
Office of Hematology and Oncology Products
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Dr. Beaver is director of the Division of Oncology Products 1 (DOP1) in the Office of Hematology Oncology Products in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA).
Dr. Beaver graduated magna cum laude from Princeton University and earned her medical degree from the University of Pennsylvania School of Medicine. She completed a residency in internal medicine at Johns Hopkins University School of Medicine, followed by a fellowship in medical oncology at The Johns Hopkins Sidney Kimmel Cancer Center.
At the FDA, Dr. Beaver served as clinical team leader of the Breast and Gynecologic Malignancies Group and associate director in DOP1 prior to assuming her role as director. She is also an assistant professor of oncology at Johns Hopkins University where she is a member of the Johns Hopkins Breast Cancer Group and sees patients with breast cancer at Johns Hopkins Oncology at Sibley Memorial Hospital.
Dr. Beaver serves on the Liquid Biopsy Blood Profiling Atlas in Cancer (Blood-PAC) committee, the ASCO Cancer Education Committee for Drug Development and Translational Research, and the ASCO/FoCR Eligibility Criteria Planning Committee. She also leads the FDA’s next generation sequencing laboratory collaboration between OHOP and the Office of Biotechnology Products.